These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23106521)

  • 41. Current drug treatment of epilepsy in adults.
    McCorry D; Chadwick D; Marson A
    Lancet Neurol; 2004 Dec; 3(12):729-35. PubMed ID: 15556805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Side-effects of antiepileptic treatment: the current state of the problem].
    Voronkova KV; Pylaeva OA; Kholin AA; Kosiakova ES; Mazal'skaia OV; Koroleva NIu; Akhmedov TM; Buchneva IA; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 2):44-51. PubMed ID: 22500332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tolerability of antiseizure medications: implications for health outcomes.
    Gilliam F; Carter J; Vahle V
    Neurology; 2004 Nov; 63(10 Suppl 4):S9-S12. PubMed ID: 15557551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Commentary: Optimize the speed, enhance the patient's life.
    Han JJ; Atluri P
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1326-1327. PubMed ID: 31375377
    [No Abstract]   [Full Text] [Related]  

  • 45. The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist.
    Patsalos PN
    Epilepsia; 2015 Jan; 56(1):12-27. PubMed ID: 25495693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Epilepsy in the aged : Challenges in diagnostics and treatment].
    Rohracher A; Trinka E
    Z Gerontol Geriatr; 2021 Jul; 54(4):395-408. PubMed ID: 33891210
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
    Macfarlane A; Greenhalgh T
    BMC Pregnancy Childbirth; 2018 Jun; 18(1):200. PubMed ID: 29859057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis.
    Zhuo C; Jiang R; Li G; Shao M; Chen C; Chen G; Tian H; Li J; Xue R; Jiang D
    Sci Rep; 2017 May; 7(1):2535. PubMed ID: 28566726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy.
    Tan J; Paquette V; Levine M; Ensom MHH
    Clin Pharmacokinet; 2017 Nov; 56(11):1267-1285. PubMed ID: 28353057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.
    Shorvon SD; Trinka E; Steinhoff BJ; Holtkamp M; Villanueva V; Peltola J; Ben-Menachem E
    J Neurol; 2017 Mar; 264(3):421-431. PubMed ID: 28101651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy.
    Armstrong TS; Grant R; Gilbert MR; Lee JW; Norden AD
    Neuro Oncol; 2016 Jun; 18(6):779-89. PubMed ID: 26527735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perampanel for focal epilepsy: insights from early clinical experience.
    Trinka E; Steinhoff BJ; Nikanorova M; Brodie MJ
    Acta Neurol Scand; 2016 Mar; 133(3):160-72. PubMed ID: 26506904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Perampanel: A Review in Drug-Resistant Epilepsy.
    Frampton JE
    Drugs; 2015 Sep; 75(14):1657-68. PubMed ID: 26370209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of anticonvulsant actions of dibromophenyl enaminones using in vitro and in vivo seizure models.
    Qaddoumi MG; Ananthalakshmi KV; Phillips OA; Edafiogho IO; Kombian SB
    PLoS One; 2014; 9(6):e99770. PubMed ID: 24945912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. USL255 extended-release topiramate: dose-proportional pharmacokinetics and tolerability in healthy volunteers.
    Clark AM; Halvorsen MB; Braun TL; Johnson KM; Cloyd JC
    Epilepsia; 2014 Jul; 55(7):1069-76. PubMed ID: 24861853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ideal characteristics of an antiepileptic drug: how do these impact treatment decisions for individual patients?
    Trinka E
    Acta Neurol Scand Suppl; 2012; (194):10-8. PubMed ID: 23106521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Considerations in the choice of an antiepileptic drug in the treatment of epilepsy.
    Azar NJ; Abou-Khalil BW
    Semin Neurol; 2008 Jul; 28(3):305-16. PubMed ID: 18777477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pregnancy in women who have epilepsy.
    Pennell PB
    Neurol Clin; 2004 Nov; 22(4):799-820. PubMed ID: 15474768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of epilepsy on patients' lives.
    Kerr MP
    Acta Neurol Scand Suppl; 2012; (194):1-9. PubMed ID: 23106520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The selection of antiepileptic drugs for the treatment of epilepsy in children and adults.
    Asconapé JJ
    Neurol Clin; 2010 Nov; 28(4):843-52. PubMed ID: 20816265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.